Nebenwirkungen · Quadramet
Quadramet 1.3 GBq/mL solution for injection. · Abschnitt 4.8 · PDF-Seite 5
HOS-087450 · Präparat HOS-083495
Summary of the safety profile In clinical studies in individuals who received Quadramet, the most frequently reported reactions were thrombocytopenia, anaemia and leukopenia. The most important serious adverse reactions associated with Quadramet are disseminated intravascular coagulation, bone marrow failure, hypersensitivity, anaphylactic reaction, intracranial haemorrhage, cerebrovascular accident and spinal cord compression.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-10-31T14:00:00Z · SHA-256 82efe65778c242182a4d448b2f4bb96ae66ce957fc21e53e2c3aa178d7307937 · Passage 098f586e70d0cbd7aa1301e6fefed9bea5da385a9eb67860394942a6f01f5ec6 · Zeichen 0–431 im Abschnitt